News
Novavax on Thursday tried to calm investors spooked by the delay of full approval of its COVID vaccine shot by U.S.
By Dennis Thompson HealthDay ReporterTUESDAY, May 6, 2025 (HealthDay News) -- The head of the U.S. Food and Drug ...
The independent experts will meet on May 22 to discuss updates to the COVID-19 vaccine for the upcoming season.
Novavax said on Thursday discussions with the U.S. health regulator on its COVID-19 shot are ongoing and a pathway to ...
Senior leaders at the FDA began pushing Moderna and Pfizer to file for full, formal approval of their COVID vaccines for ...
A new vaccine that combines flu and COVID-19 protection in one shot shows promising results, but the U.S. Food and Drug ...
The advisory committee meeting is an important step in the process of readying boosters for the fall and winter season, but ...
Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...
Steven J. Hatfill, who still thinks malaria drugs can treat COVID-19, said he will “help get us ready for the next pandemic.” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results